Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Enasidenib Market Research Report 2026

Global Enasidenib Market Research Report 2026

Industry: Pharma & Healthcare

Published Date: 2026-04-27

Pages: 106 Pages

Report ld: 6653611

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Enasidenib Market Size(US$)

CAGR 2026-2032

7.1%

Market Size,2032

USD 152

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 100 million

Market Forecast in 2032(Value)

US$ 152 million

CAGR

7.1%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Enasidenib market was valued at US$ 94.4 million in 2025 and is anticipated to reach US$ 152 million by 2032, at a CAGR of 7.1% from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Enasidenib competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test

Enasidenib is a targeted therapy used to treat relapsed or refractory acute myeloid leukemia (AML) with an IDH2 mutation. Its efficacy in inhibiting the mutated IDH2 enzyme and inducing remission has driven market growth. The limited treatment options for this specific subset of AML contribute to its niche status. However, challenges include potential side effects and the need for genetic testing to identify eligible patients. The market competition is relatively small, as Enasidenib remains a targeted therapy for a specific AML subgroup. Despite challenges, the Enasidenib market offers potential for growth as healthcare providers seek effective treatments for patients with IDH2-mutated AML. Continued research and clinical advancements can further drive market expansion.

This report delivers a comprehensive overview of the global Enasidenib market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Enasidenib. The Enasidenib market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Enasidenib market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Enasidenib manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

Bristol Myers Squibb

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

50mg
100mg

Segment by Application

Hospital
Pharmacy

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

Chapter 2: Provides a detailed analysis of the competitive landscape for Enasidenib manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.

Chapter 3: Examines Enasidenib sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.

Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.

Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.

Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.

Chapter 7: Reviews the industry value chain, including upstream and downstream segments.

Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.

Chapter 9: Summarizes the key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Enasidenib Market Overview

1.1 Product Definition

1.2 Enasidenib by Type

1.2.1 Global Enasidenib Market Value by Type: 2025 vs 2032

1.2.2 50mg

1.2.3 100mg

1.3 Enasidenib by Application

1.3.1 Global Enasidenib Market Value by Application: 2025 vs 2032

1.3.2 Hospital

1.3.3 Pharmacy

1.4 Global Enasidenib Market Size Estimates and Forecasts

1.4.1 Global Enasidenib Revenue 2021–2032

1.4.2 Global Enasidenib Sales 2021–2032

1.4.3 Global Enasidenib Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2 Enasidenib Market Competition by Manufacturers

2.1 Global Enasidenib Sales Market Share by Manufacturers (2021–2026)

2.2 Global Enasidenib Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Enasidenib Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Enasidenib, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Enasidenib, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Enasidenib, Product Types and Applications

2.7 Global Key Manufacturers of Enasidenib, Date of Entry into the Industry

2.8 Global Enasidenib Market Competitive Situation and Trends

2.8.1 Global Enasidenib Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Enasidenib Players Market Share by Revenue

2.8.3 Global Enasidenib Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Enasidenib Market Scenario by Region

3.1 Global Enasidenib Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Enasidenib Sales by Region: 2021–2032

3.2.1 Global Enasidenib Sales by Region: 2021–2026

3.2.2 Global Enasidenib Sales by Region: 2027–2032

3.3 Global Enasidenib Revenue by Region: 2021–2032

3.3.1 Global Enasidenib Revenue by Region: 2021–2026

3.3.2 Global Enasidenib Revenue by Region: 2027–2032

3.4 North America Enasidenib Market Facts & Figures by Country

3.4.1 North America Enasidenib Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Enasidenib Sales by Country (2021–2032)

3.4.3 North America Enasidenib Revenue by Country (2021–2032)

3.4.4 the United States

3.4.5 Canada

3.5 Europe Enasidenib Market Facts & Figures by Country

3.5.1 Europe Enasidenib Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Enasidenib Sales by Country (2021–2032)

3.5.3 Europe Enasidenib Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 UK

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Enasidenib Market Facts & Figures by Region

3.6.1 Asia Pacific Enasidenib Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Enasidenib Sales by Region (2021–2032)

3.6.3 Asia Pacific Enasidenib Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Enasidenib Market Facts & Figures by Country

3.7.1 Latin America Enasidenib Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Enasidenib Sales by Country (2021–2032)

3.7.3 Latin America Enasidenib Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Enasidenib Market Facts & Figures by Country

3.8.1 Middle East and Africa Enasidenib Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Enasidenib Sales by Country (2021–2032)

3.8.3 Middle East and Africa Enasidenib Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Enasidenib Sales by Type (2021–2032)

4.1.1 Global Enasidenib Sales by Type (2021–2026)

4.1.2 Global Enasidenib Sales by Type (2027–2032)

4.1.3 Global Enasidenib Sales Market Share by Type (2021–2032)

4.2 Global Enasidenib Revenue by Type (2021–2032)

4.2.1 Global Enasidenib Revenue by Type (2021–2026)

4.2.2 Global Enasidenib Revenue by Type (2027–2032)

4.2.3 Global Enasidenib Revenue Market Share by Type (2021–2032)

4.3 Global Enasidenib Price by Type (2021–2032)

5 Segment by Application

5.1 Global Enasidenib Sales by Application (2021–2032)

5.1.1 Global Enasidenib Sales by Application (2021–2026)

5.1.2 Global Enasidenib Sales by Application (2027–2032)

5.1.3 Global Enasidenib Sales Market Share by Application (2021–2032)

5.2 Global Enasidenib Revenue by Application (2021–2032)

5.2.1 Global Enasidenib Revenue by Application (2021–2026)

5.2.2 Global Enasidenib Revenue by Application (2027–2032)

5.2.3 Global Enasidenib Revenue Market Share by Application (2021–2032)

5.3 Global Enasidenib Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Bristol Myers Squibb

6.1.1 Bristol Myers Squibb Company Information

6.1.2 Bristol Myers Squibb Description and Business Overview

6.1.3 Bristol Myers Squibb Enasidenib Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Bristol Myers Squibb Enasidenib Product Portfolio

6.1.5 Bristol Myers Squibb Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Enasidenib Industry Chain Analysis

7.2 Enasidenib Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Enasidenib Production Mode & Process Analysis

7.4 Enasidenib Sales and Marketing

7.4.1 Enasidenib Sales Channels

7.4.2 Enasidenib Distributors

7.5 Enasidenib Customer Analysis

8 Enasidenib Market Dynamics

8.1 Enasidenib Industry Trends

8.2 Enasidenib Market Drivers

8.3 Enasidenib Market Challenges

8.4 Enasidenib Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Enasidenib Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Enasidenib Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Enasidenib Market Competitive Situation by Manufacturers in 2025

Table 4. Global Enasidenib Sales (Units) of Key Manufacturers (2021–2026)

Table 5. Global Enasidenib Sales Market Share by Manufacturers (2021–2026)

Table 6. Global Enasidenib Revenue (US$ Million) by Manufacturers (2021–2026)

Table 7. Global Enasidenib Revenue Share by Manufacturers (2021–2026)

Table 8. Global Market Enasidenib Average Price (USD/Unit) of Key Manufacturers (2021–2026)

Table 9. Global Key Players of Enasidenib, Industry Ranking, 2023 vs 2024 vs 2025

Table 10. Global Key Manufacturers of Enasidenib, Manufacturing Sites and Headquarters

Table 11. Global Key Manufacturers of Enasidenib, Product Types and Applications

Table 12. Global Key Manufacturers of Enasidenib, Date of Entry into the Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Enasidenib Companies by Tier (Tier 1, Tier 2, Tier 3), based on Enasidenib Revenue, 2025

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Enasidenib Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Enasidenib Sales by Region (Units), 2021–2026

Table 18. Global Enasidenib Sales Market Share by Region (2021–2026)

Table 19. Global Enasidenib Sales by Region (Units), 2027–2032

Table 20. Global Enasidenib Sales Market Share by Region (2027–2032)

Table 21. Global Enasidenib Revenue by Region (US$ Million), 2021–2026

Table 22. Global Enasidenib Revenue Market Share by Region (2021–2026)

Table 23. Global Enasidenib Revenue by Region (US$ Million), 2027–2032

Table 24. Global Enasidenib Revenue Market Share by Region (2027–2032)

Table 25. North America Enasidenib Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 26. North America Enasidenib Sales by Country (Units), 2021–2026

Table 27. North America Enasidenib Sales by Country (Units), 2027–2032

Table 28. North America Enasidenib Revenue by Country (US$ Million), 2021–2026

Table 29. North America Enasidenib Revenue by Country (US$ Million), 2027–2032

Table 30. Europe Enasidenib Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 31. Europe Enasidenib Sales by Country (Units), 2021–2026

Table 32. Europe Enasidenib Sales by Country (Units), 2027–2032

Table 33. Europe Enasidenib Revenue by Country (US$ Million), 2021–2026

Table 34. Europe Enasidenib Revenue by Country (US$ Million), 2027–2032

Table 35. Asia Pacific Enasidenib Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Asia Pacific Enasidenib Sales by Region (Units), 2021–2026

Table 37. Asia Pacific Enasidenib Sales by Region (Units), 2027–2032

Table 38. Asia Pacific Enasidenib Revenue by Region (US$ Million), 2021–2026

Table 39. Asia Pacific Enasidenib Revenue by Region (US$ Million), 2027–2032

Table 40. Latin America Enasidenib Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Latin America Enasidenib Sales by Country (Units), 2021–2026

Table 42. Latin America Enasidenib Sales by Country (Units), 2027–2032

Table 43. Latin America Enasidenib Revenue by Country (US$ Million), 2021–2026

Table 44. Latin America Enasidenib Revenue by Country (US$ Million), 2027–2032

Table 45. Middle East and Africa Enasidenib Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 46. Middle East and Africa Enasidenib Sales by Country (Units), 2021–2026

Table 47. Middle East and Africa Enasidenib Sales by Country (Units), 2027–2032

Table 48. Middle East and Africa Enasidenib Revenue by Country (US$ Million), 2021–2026

Table 49. Middle East and Africa Enasidenib Revenue by Country (US$ Million), 2027–2032

Table 50. Global Enasidenib Sales (Units) by Type (2021–2026)

Table 51. Global Enasidenib Sales (Units) by Type (2027–2032)

Table 52. Global Enasidenib Sales Market Share by Type (2021–2026)

Table 53. Global Enasidenib Sales Market Share by Type (2027–2032)

Table 54. Global Enasidenib Revenue (US$ Million) by Type (2021–2026)

Table 55. Global Enasidenib Revenue (US$ Million) by Type (2027–2032)

Table 56. Global Enasidenib Revenue Market Share by Type (2021–2026)

Table 57. Global Enasidenib Revenue Market Share by Type (2027–2032)

Table 58. Global Enasidenib Price (USD/Unit) by Type (2021–2026)

Table 59. Global Enasidenib Price (USD/Unit) by Type (2027–2032)

Table 60. Global Enasidenib Sales (Units) by Application (2021–2026)

Table 61. Global Enasidenib Sales (Units) by Application (2027–2032)

Table 62. Global Enasidenib Sales Market Share by Application (2021–2026)

Table 63. Global Enasidenib Sales Market Share by Application (2027–2032)

Table 64. Global Enasidenib Revenue (US$ Million) by Application (2021–2026)

Table 65. Global Enasidenib Revenue (US$ Million) by Application (2027–2032)

Table 66. Global Enasidenib Revenue Market Share by Application (2021–2026)

Table 67. Global Enasidenib Revenue Market Share by Application (2027–2032)

Table 68. Global Enasidenib Price (USD/Unit) by Application (2021–2026)

Table 69. Global Enasidenib Price (USD/Unit) by Application (2027–2032)

Table 70. Bristol Myers Squibb Company Information

Table 71. Bristol Myers Squibb Description and Business Overview

Table 72. Bristol Myers Squibb Enasidenib Sales (Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)

Table 73. Bristol Myers Squibb Enasidenib Product

Table 74. Bristol Myers Squibb Recent Developments/Updates

Table 75. Key Raw Materials Lists

Table 76. Raw Materials Key Suppliers Lists

Table 77. Enasidenib Distributors List

Table 78. Enasidenib Customers List

Table 79. Enasidenib Market Trends

Table 80. Enasidenib Market Drivers

Table 81. Enasidenib Market Challenges

Table 82. Enasidenib Market Restraints

Table 83. Research Programs/Design for This Report

Table 84. Key Data Information from Secondary Sources

Table 85. Key Data Information from Primary Sources

Table 86. Authors List of This Report

List of Figures

Figure 1. Product Picture of Enasidenib

Figure 2. Global Enasidenib Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Enasidenib Market Share by Type: 2025 & 2032

Figure 4. 50mg Product Picture

Figure 5. 100mg Product Picture

Figure 6. Global Enasidenib Market Value by Application (US$ Million), 2021–2032

Figure 7. Global Enasidenib Market Share by Application: 2025 & 2032

Figure 8. Hospital

Figure 9. Pharmacy

Figure 10. Global Enasidenib Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 11. Global Enasidenib Market Size (US$ Million), 2021–2032

Figure 12. Global Enasidenib Sales (Units), 2021–2032

Figure 13. Global Enasidenib Average Price (USD/Unit), 2021–2032

Figure 14. Enasidenib Report Years Considered

Figure 15. Enasidenib Sales Share by Manufacturers in 2025

Figure 16. Global Enasidenib Revenue Share by Manufacturers in 2025

Figure 17. Top 5 and Top 10 Global Enasidenib Players: Market Share by Revenue in Enasidenib in 2025

Figure 18. Enasidenib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 19. Global Enasidenib Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 20. North America Enasidenib Sales Market Share by Country (2021–2032)

Figure 21. North America Enasidenib Revenue Market Share by Country (2021–2032)

Figure 22. the United States Enasidenib Revenue Growth Rate (US$ Million), 2021–2032

Figure 23. Canada Enasidenib Revenue Growth Rate (US$ Million), 2021–2032

Figure 24. Europe Enasidenib Sales Market Share by Country (2021–2032)

Figure 25. Europe Enasidenib Revenue Market Share by Country (2021–2032)

Figure 26. Germany Enasidenib Revenue Growth Rate (US$ Million), 2021–2032

Figure 27. France Enasidenib Revenue Growth Rate (US$ Million), 2021–2032

Figure 28. UK Enasidenib Revenue Growth Rate (US$ Million), 2021–2032

Figure 29. Italy Enasidenib Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. Russia Enasidenib Revenue Growth Rate (US$ Million), 2021–2032

Figure 31. Asia Pacific Enasidenib Sales Market Share by Region (2021–2032)

Figure 32. Asia Pacific Enasidenib Revenue Market Share by Region (2021–2032)

Figure 33. China Enasidenib Revenue Growth Rate (US$ Million), 2021–2032

Figure 34. Japan Enasidenib Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. South Korea Enasidenib Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. India Enasidenib Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. Australia Enasidenib Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. China Taiwan Enasidenib Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. Indonesia Enasidenib Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Thailand Enasidenib Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Malaysia Enasidenib Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Latin America Enasidenib Sales Market Share by Country (2021–2032)

Figure 43. Latin America Enasidenib Revenue Market Share by Country (2021–2032)

Figure 44. Mexico Enasidenib Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Brazil Enasidenib Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Argentina Enasidenib Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Middle East and Africa Enasidenib Sales Market Share by Country (2021–2032)

Figure 48. Middle East and Africa Enasidenib Revenue Market Share by Country (2021–2032)

Figure 49. Turkey Enasidenib Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Saudi Arabia Enasidenib Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. UAE Enasidenib Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Global Sales Market Share of Enasidenib by Type (2021–2032)

Figure 53. Global Revenue Market Share of Enasidenib by Type (2021–2032)

Figure 54. Global Enasidenib Price (USD/Unit) by Type (2021–2032)

Figure 55. Global Sales Market Share of Enasidenib by Application (2021–2032)

Figure 56. Global Revenue Market Share of Enasidenib by Application (2021–2032)

Figure 57. Global Enasidenib Price (USD/Unit) by Application (2021–2032)

Figure 58. Enasidenib Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Enasidenib market size from 2026 to 2032? zhanKai

The annual compound growth rate of the global Enasidenib market is 7.1% 2026 to 2032.

Which companies rank high in the global Enasidenib market? shouQi

What was the global market size of Enasidenib in 2026? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Enasidenib in 2032? shouQi

Related Reports

Enasidenib- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Enasidenib was estimated to be worth US$ 94.4 million in 2025 and is projected to reach US$ 152 million, growing at a CAGR of 7.1% from 2026 to 2032.
Published Date: 2026-07-14
Pages: 125
USD 3950.00
(Single User License)
Global Enasidenib Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Enasidenib market size was US$ 88.7 million in 2024 and is forecast to a readjusted size of US$ 142 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 70
USD 4250.00
(Single User License)
Enasidenib- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Enasidenib was estimated to be worth US$ 88.7 million in 2024 and is forecast to a readjusted size of US$ 142 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 87
USD 3950.00
(Single User License)
Global Enasidenib Market Research Report 2025
The global market for Enasidenib was valued at US$ 88.7 million in the year 2024 and is projected to reach a revised size of US$ 142 million by 2031, growing at a CAGR of 7.1% during the forecast period.
Published Date: 2025-02-25
Pages: 74
USD 2900.00
(Single User License)
Global Enasidenib Market Insights, Forecast to 2030
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
Published Date: 2024-04-25
Pages: 72
USD 4900.00
(Single User License)
Enasidenib - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
Published Date: 2024-01-24
Pages: 89
USD 3950.00
(Single User License)
Global Enasidenib Market Research Report 2024
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
Published Date: 2024-01-05
Pages: 67
USD 2900.00
(Single User License)

Enasidenib- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Enasidenib was estimated to be worth US$ 94.4 million in 2025 and is projected to reach US$ 152 million, growing at a CAGR of 7.1% from 2026 to 2032.
Published: 2026-07-14
Pages: 125
USD 3950.00 (Single User License)
Global Enasidenib Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Enasidenib market size was US$ 88.7 million in 2024 and is forecast to a readjusted size of US$ 142 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 70
USD 4250.00 (Single User License)
Enasidenib- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Enasidenib was estimated to be worth US$ 88.7 million in 2024 and is forecast to a readjusted size of US$ 142 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 87
USD 3950.00 (Single User License)
Global Enasidenib Market Research Report 2025
The global market for Enasidenib was valued at US$ 88.7 million in the year 2024 and is projected to reach a revised size of US$ 142 million by 2031, growing at a CAGR of 7.1% during the forecast period.
Published: 2025-02-25
Pages: 74
USD 2900.00 (Single User License)
Global Enasidenib Market Insights, Forecast to 2030
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
Published: 2024-04-25
Pages: 72
USD 4900.00 (Single User License)
Enasidenib - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
Published: 2024-01-24
Pages: 89
USD 3950.00 (Single User License)
Global Enasidenib Market Research Report 2024
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
Published: 2024-01-05
Pages: 67
USD 2900.00 (Single User License)